Session Abstract – PMWC 2022 Silicon Valley


Qatar Foundation’s Sidra Medicine is a leading regional research hospital and tertiary care facility for women and children, seeing nearly 200,000 patients in 2020. This session will explore the work at Sidra Medicine to take from bench to bedside the applications arising from newly analysed datasets of the Arab genome that will have benefits for patient care, pharmacogenomics and population health.

 Session Chair Profile

Ph.D., Chief Research Officer, Sidra Medicine

Biography
Dr. Khalid A. Fakhro is the Chief Research Officer at Sidra Medicine and the Director of the healthcare facility’s Precision Medicine program. Dr. Fakhro joined Sidra Medicine as a Principal Investigator in July 2014, and became Director of the Human Genetics department, where he built a robust genomic medicine research pipeline for the hospital. In 2018, he became the inaugural Director of Precision Medicine at Sidra, heading an ambitious program where research in genomics and personalized medicine are embedded in the heart of Sidra Medicine’s academic medical enterprise. Prior to joining Sidra Medicine, Dr. Fakhro was part of the Department of Genetic Medicine at Weill-Cornell Medicine in Qatar. Dr. Fakhro graduated with Honors from the University of Chicago (USA) majoring in Biological Sciences with specialization in Cellular Biology and Molecular Genetics, and later completed his PhD in Human Genetics at Yale University (USA), where he was part of a highly selective HHMI Translational Medicine Scholars program, designed to train basic scientists to take discoveries from the bench to bedside. He holds adjunct faculty appointments at both Weill-Cornell Medicine and at Hamad bin Khalifa University, where he teaches classes and mentors the next generation of Masters and PhD students in human genetics and genomic medicine.


 Speaker Profile

M.D., M.P.H., Chief Medical Officer, Sidra Medicine

Biography
Ziyad M. Hijazi, MD, MPH is the Chief Medical Officer at Sidra Medicine, a specialist women’s and children’s healthcare facility in the State of Qatar. He was appointed to the role in April 2021. As CMO of Sidra Medicine, Prof. Hijazi is responsible for the overall management of the hospital’s clinical operations, upholding its clinical excellence and patient safety programs and ensuring that patients in Qatar receive the highest standard of medical care. Prof. Hijazi has nearly 40 years of experience in pediatric cardiology and has pioneered several ground-breaking surgical procedures in the field. He is an internationally recognized leader in the nonsurgical repair of congenital and structural heart defects and in the development of novel trans-catheter devices. Prof. Hijazi joined Sidra Medicine in 2014, during which time he established the hospital’s Department of Pediatrics and world-class Heart Center; staffed by some of the top pediatric specialists and healthcare professionals from across the globe. The Heart Center provides preventative, medical and surgical care for patients with congenital or acquired heart disease. Prof. Hijazi also successfully set up Sidra Medicine’s International Medical Office which has facilitated international patients to access to several specialist services, including cardiology, urology, plastics and neurosurgery among others. Over the course of three years, Sidra Medicine has saved the lives of hundreds of children from the MENA region, including India, Pakistan, North and South America. Pof. Hijazi is the Editor-in-Chief of the Journal of Structural Heart Disease. Has more than 350 manuscripts in peer reviewed journals and edited eight books. He is also the course director for the Pediatric Interventional Cardiac Symposium (PICS), which annually attracts more than 800 professionals from more than 60 countries.


 Speaker Profile

M.D., President and CEO, The Jackson Labs

Biography
Edison T. Liu, M.D. is a global leader in translational genomic medicine who has been at the helm of research institutions in US academia, the US National Cancer Institute, and in Asia. He propelled Singapore’s genomics efforts onto the international stage, helping that country become a regional powerhouse in biomedical sciences. In the last ten years, Dr. Liu guided The Jackson Laboratory to a doubling of its size and revenues, and expanded its footprint from North America into China and Japan. As an active physician scientist, his research is centered on the complex genetics of human cancers with a special focus on the genomic biology of breast cancer. Dr. Liu has published over 320 papers, reviews, and books, and is a recipient of numerous national and international awards. He is an advisor to many institutions across the world seeking to establish a competitive position in the global biomedical sciences.